hemangiol
pierre fabre medicament - propranololio hidrochloridas - hemangioma - beta blokatoriai - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
propranolol actavis
teva b.v. - propranololis - plėvele dengtos tabletės - 40 mg - propranolol
propranolol teva
nenurodyta - propranololis - tabletės - 40 mg - propranolol
propranolol arena
nenurodyta - propranololis - tabletės - 40 mg - propranolol
propranolol accord
actiofarma, uab - propranololis - plėvele dengtos tabletės - 40 mg - propranolol
propranolol accord
lex ano, uab - propranololis - plėvele dengtos tabletės - 40 mg - propranolol
propranolol accord
niromed, uab - propranololis - plėvele dengtos tabletės - 40 mg - propranolol
propranolol accord
lex ano, uab - propranololis - plėvele dengtos tabletės - 40 mg - propranolol